Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Litt

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Vaccine|April 22, 2022
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccineHelen J Mayfield, Colleen L Lau, Jane E Sinclair, et al.
Vaccine|November 23, 2021
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling frameworkColleen L Lau, Helen J Mayfield, Jane E Sinclair, et al.
Health and Quality of Life Outcomes|May 5, 2016
The impact of health literacy and life style risk factors on health-related quality of life of Australian patientsUpali W Jayasinghe, Mark Fort Harris, Sharon M Parker, et al.
Sozial- Und Praventivmedizin|July 24, 2002
Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaignsDavid Wilson, Rosemary Lester, Anne Taylor, et al.
BMC Health Services Research|September 10, 2017
An Australian general practice based strategy to improve chronic disease prevention, and its impact on patient reported outcomes: evaluation of the preventive evidence into practice cluster randomised controlled trialMark Fort Harris, Sharon M Parker, John Litt, et al.
BMJ Open|December 15, 2015
Implementing guidelines to routinely prevent chronic vascular disease in primary care: the Preventive Evidence into Practice cluster randomised controlled trialMark Fort Harris, Sharon M Parker, John Litt, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|September 5, 2008
IPCRG Consensus statement: tackling the smoking epidemic - practical guidance for primary careOnno C P van Schayck, Hilary Pinnock, Anders Ostrem, et al.
Thorax|September 21, 2012
Smoking Termination Opportunity for inPatients (STOP): superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 12-month randomised controlled trial for inpatientsBrian James Smith, Kristin Veronica Carson, Malcolm Philip Brinn, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 18, 2014
Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study)Kristin Veronica Carson, Brian James Smith, Malcolm Philip Brinn, et al.
Plos One|December 30, 2021
Correction: Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trialKristin V Carson-Chahhoud, Brian J Smith, Matthew J Peters, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Vaccine|April 22, 2022
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccineHelen J Mayfield, Colleen L Lau, Jane E Sinclair, et al.
Vaccine|November 23, 2021
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling frameworkColleen L Lau, Helen J Mayfield, Jane E Sinclair, et al.
Health and Quality of Life Outcomes|May 5, 2016
The impact of health literacy and life style risk factors on health-related quality of life of Australian patientsUpali W Jayasinghe, Mark Fort Harris, Sharon M Parker, et al.
Sozial- Und Praventivmedizin|July 24, 2002
Prevalence of influenza immunisation in Australia and suggestions for future targeting of campaignsDavid Wilson, Rosemary Lester, Anne Taylor, et al.
BMC Health Services Research|September 10, 2017
An Australian general practice based strategy to improve chronic disease prevention, and its impact on patient reported outcomes: evaluation of the preventive evidence into practice cluster randomised controlled trialMark Fort Harris, Sharon M Parker, John Litt, et al.
BMJ Open|December 15, 2015
Implementing guidelines to routinely prevent chronic vascular disease in primary care: the Preventive Evidence into Practice cluster randomised controlled trialMark Fort Harris, Sharon M Parker, John Litt, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|September 5, 2008
IPCRG Consensus statement: tackling the smoking epidemic - practical guidance for primary careOnno C P van Schayck, Hilary Pinnock, Anders Ostrem, et al.
Thorax|September 21, 2012
Smoking Termination Opportunity for inPatients (STOP): superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 12-month randomised controlled trial for inpatientsBrian James Smith, Kristin Veronica Carson, Malcolm Philip Brinn, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 18, 2014
Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study)Kristin Veronica Carson, Brian James Smith, Malcolm Philip Brinn, et al.
Plos One|December 30, 2021
Correction: Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trialKristin V Carson-Chahhoud, Brian J Smith, Matthew J Peters, et al.
Pageof 4